GlassScriptPhysician profile
Tiffany Shaughnessy
NPI 1952980518
$2,790.59
in general payments reported to CMS, 2019-2025
13 companies · $749 in 2025
The $749 reported for 2025 was more than what 75% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $392 · 2022: $518 · 2023: $413 · 2024: $719 · 2025: $749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,880.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $728.95 | 2021-2025 | Caplyta |
| Abbvie INC. | $684.38 | 2022-2025 | |
| Alkermes, INC. | $267.22 | 2021-2025 | Lybalvi, Aristada |
| Neurocrine Biosciences, INC. | $185.60 | 2021-2025 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $174.67 | 2023-2025 | Abilify Asimtufii, Abilify Maintena |
| Sunovion Pharmaceuticals INC. | $172.50 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $164.93 | 2023 | Spravato |
| Galderma Laboratories, L.P. | $142.43 | 2024 | |
| Axsome Therapeutics, INC. | $128.18 | 2023-2024 | Auvelity |
| E.R. Squibb & Sons, L.L.C. | $83.75 | 2025 | Cobenfy |
| Teva Pharmaceuticals USA, INC. | $35.63 | 2023-2025 | Austedo Xr, Uzedy |
| Luye Pharma (USA) LTD. | $14.63 | 2025 | Erzofri Extended-Release |
| Corium, LLC | $7.72 | 2025 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Shaughnessy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.